Apollo AyurVAID Hospitals, a part of the Apollo Hospitals Group, launched its state-of-the-art 35-bed hospital at Greams Road, Chennai. This new facility marks an important milestone in integrating Ayurveda with modern science, emphasising evidence-based, personalised care for complex non-communicable diseases and rehabilitation. The facility offers treatment in various specialties that include orthopedics, neuro and neurodegenerative disorders, metabolic and women's health issues, pediatric developmental disorders, elder care, and sports medicine. It also provides Ayurvedic para-surgical treatments for conditions such as anorectal problems, chronic wounds, and respiratory issues. The hospital seeks to merge traditional practices with modern clinical systems to offer holistic health solutions. Apollo AyurVAID is launched by Dr. Prathap C. Reddy, Founder-Chairman of Apollo Hospitals, in the presence of Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., and Mr. Rajiv Vasudevan, Founder and Managing Director of Apollo AyurVAID Hospitals. Dr. Reddy termed Ayurveda one of the biggest gifts that India had ever given to the world, underlining its potential when practiced with precision, evidence, and safety. He said he was confident that the new hospital would be an icon of research-led, Ayurvedic healthcare, leading towards recovery and lifelong wellness. Dr. Preetha Reddy spoke of the restoration of body-mind balance and promotion of lifetime wellness by the hospital. She spoke about the ever-growing network of Apollo, covering all the four southern states, Delhi, and upcoming western and eastern parts of India, with a commitment toward holistic, patient-centric healthcare. Mr. Rajiv Vasudevan emphasised that Apollo AyurVAID Hospitals is committed to offering personalised care for root-cause diagnosis and treatment of complex non-communicable diseases, post-acute rehabilitation, and whole-person health, with the aim of making high-quality, safe, outcome-driven Ayurveda care accessible to all seeking holistic healing. Further, Apollo AyurVAID will provide the line of ‘Tested Safe’ AyurVaid products, a range that undergoes stringent quality testing. Safety reports can be checked by consumers via QR codes; thus, quality and transparency go hand in hand.

In a landmark partnership, Apollo Hospitals and Navi Mumbai International Airport have come together in the endeavour to establish advanced 24/7 medical centres at Terminal 1 of the airport, strengthening health accessibility for passengers, staff, and the community around the airport. This collaboration, inked through a recent Memorandum of Understanding (MoU), guarantees round-the-clock preparedness for any medical eventualities with facilities equipped to handle emergencies and disaster management.  This will involve setting up six medical centres, each manned by three doctors, eight nurses, and two drivers, all of whom will be Advanced Cardiovascular Life Support (ACLS) trained to provide competent critical care. In addition to these facilities, the airport will have two completely equipped Intensive Care Unit (ICU) ambulances for immediate emergency services. There are also 65 Automated External Defibrillators (AEDs) placed throughout the terminals for quick responses to cardiac emergencies.  Apollo Hospitals Navi Mumbai, only a few kilometres from the airport, will further drive emergency and disaster preparedness at the facility, thereby enhancing the ecosystem of safety. This is a shared commitment to embedding quality healthcare into the travel experience, in line with Apollo's mission under the leadership of Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., to make advanced healthcare accessible and reliable.  The integration of Apollo Hospitals' expertise with Navi Mumbai Airport's infrastructure aims at the delivery of not only timely emergency care but also an assuring healthcare presence round the clock for travellers and airport personnel. 

CNBC-TV18 honoured Dr. Prathap C Reddy, Founder and Chairman of Apollo Hospitals, on 7 November 2025 for his pioneering and enduring contributions to Indian healthcare. Dr. Reddy is widely regarded as a visionary who transformed the nation’s private healthcare landscape when he established Apollo Hospitals in 1983. His mission — to make world-class medical care accessible and affordable for every Indian — sparked a paradigm shift that continues to shape the sector today.  Dr. Reddy’s work has been instrumental in reversing the brain drain of Indian doctors. His commitment to building a strong, ethical, and quality-driven medical ecosystem encouraged thousands of skilled Indian clinicians working abroad to return home and serve their own people. His advocacy for preventive healthcare helped make routine health checks, early diagnosis, and patient awareness a mainstream practice across the country, benefiting millions.  Under his leadership, Apollo Hospitals has grown into Asia’s largest integrated healthcare network, encompassing advanced multi-specialty hospitals, a nationwide pharmacy chain, primary care and diagnostics centres, and one of the region’s strongest telemedicine footprints. His efforts also positioned India as a global hub for medical tourism, bringing patients from over 140 countries and contributing significantly to the nation’s health economy.  During the COVID-19 pandemic, Dr. Reddy played a crucial leadership role in driving comprehensive national response initiatives — from large-scale testing and vaccination programmes to telehealth expansion and critical-care support — impacting millions of lives at a time when the country needed it most.  Over the decades, Dr. Reddy has been honoured with numerous awards, including the Padma Vibhushan and Padma Bhushan, for his unparalleled service to healthcare and his contributions to India’s growth story. His legacy continues to guide the sector toward a future defined by quality, innovation, equitable access, and a steadfast belief that good health is the foundation of a stronger India. 

Chennai, November 20, 2025: In a major step in Tamil Nadu’s healthcare landscape, Apollo Hospitals Greams Lane introduces the state’s first Centre of Excellence for Parkinson’s Disease and Deep Brain Stimulation (DBS), a comprehensive Parkinson’s care and advanced neurosurgical innovation. With a foundation built on rigorous clinical expertise, precision neurosurgery, and a seamlessly integrated care model, the centre has consistently delivered outstanding outcomes for patients from across India and neighbouring South Asian countries.Over the past four years, the Apollo Advanced Movement Disorders & DBS Centre has performed the highest number of DBS procedures in Tamil Nadu, placing it among the leading programs in South India. The team is highly experienced in next-generation brain-sensing DBS technologies, enabling personalised stimulation strategies that significantly improve mobility, independence, and overall quality of life.The centre is jointly led by, Dr. Vijayashankar Paramanandam, Senior Consultant Neurologist & Movement Disorders Specialist, and Dr. Arvind Sukumaran, Senior Consultant Functional Neurosurgeon. Both specialists have undergone advanced international training in movement disorders and functional neurosurgery, bringing global best practices into Apollo Hospitals’ structured, protocol-driven DBS program. Their collaboration ensures that every patient receives detailed evaluation, precision-based surgery, and long-term personalised programming.Speaking on this occasion, Dr. Ilankumaran Kaliamoorthy, CEO Apollo Hospitals Chennai Region said, “At Apollo Hospitals, our mission is to bring the most advanced healthcare to every individual who seeks our care. The progress made by the Apollo Advanced Movement Disorders & DBS Centre reflect our commitment to clinical excellence, precision, and compassion. With internationally trained expertise and cutting-edge brain-sensing technologies, our team is transforming the lives of patients living with Parkinson’s disease. We are proud to emerge as one of the leading centres for DBS in Tamil Nadu, offering renewed hope, restored independence, and a better quality of life for patients and their families.” Emphasising DBS as a deeply personalised and continuous treatment journey, Dr. Vijayashankar Paramanandam, Senior Consultant Neurologist & Movement Disorders Specialist, Apollo Hospitals Greams Lane, Chennai said, “There are no shortcuts in DBS surgery. The clinical decision-making begins months before the procedure. Our goal is to align clinical judgment with technology, so that each patient receives the most appropriate and thoughtful therapy possible. DBS is far more than a surgical procedure; it is a continuum of care. Its success depends not only on precise implantation, but on expert, individualised programming tailored to each patient’s symptom profile, translating stimulation into meaningful and sustained improvement. Our aim is to give patients back their movement, their confidence, and ultimately, their life.”Highlighting the exacting standards required for DBS surgery, Dr. Arvind Sukumaran, Senior Consultant Functional Neurosurgeon, Apollo Children’s Hospitals, Chennai said, “DBS placement is never target practice of just about “hitting the nucleus”. It involves understanding each patient’s functional anatomy, the link between every contact and clinical effect, and refusing to compromise on any aspect of technique or safety. Training across high-volume international centres gives us the bandwidth to integrate the latest technology where it truly matters, while keeping the fundamentals uncompromised. The principle is simple: get it right, every time, with safety at the core.”Apollo Hospitals Greams Lane’s commitment to early adoption of advanced technologies is evident through the team having performed India’s first Medtronic BrainSense™ DBS surgery, which incorporates real-time neural sensing and adaptive stimulation. This milestone demonstrates the centre’s dedication to using evidence-based technology to refine and improve long-term patient outcomes.The comprehensive DBS pathway at Apollo Hospitals Greams Lane includes advanced neuroimaging, electrophysiological mapping, individualised surgical planning, protocol-driven implantation, and long-term follow-up with expert programming, ensuring that every step meets uncompromised standards of precision and safety.For individuals living with advanced Parkinson’s disease, DBS provides the possibility of restored mobility, stability, and independence. With its multidisciplinary expertise and patient-centric approach, Apollo Hospitals Greams Lane continues to advance the practice of DBS in India, offering renewed confidence and a better quality of life to patients and their families across South Asia.

In celebration of Children’s Day, Apollo Children’s Hospital, in collaboration with the Apollo Shine Foundation, launched an innovative and heartwarming initiative titled “Happy Hearts” – first of its kind program connecting school students with young patients through letters, smiles, and shared moments of joy.The Happy Hearts Program aims to foster empathy, connection, and emotional healing by encouraging school students to spend time with paediatric patients, exchange letters of hope, and contribute to a newly unveiled Wish Wall. The wall, now a vibrant centerpiece at Apollo Children’s Hospital, showcases heartfelt messages and drawings created by students from over 10 schools across Chennai. Each note symbolizes a bridge of compassion between children in classrooms and those undergoing treatment. The event saw enthusiastic participation from students who brought handmade cards, interacted with patients, and shared stories, laughter, and encouragement — reminding everyone that healing goes beyond medicine. The young visitors also sang cheerful songs, recited poems, and presented creative activities designed to spread joy among the children receiving care. The hospital wards echoed with music, laughter, and hope, turning the day into a celebration of togetherness and empathy. Mrs. Shobha Viswanath, Director of Karadi Tales and Miss. Neha Girish, Vijay TV Junior Super Singer, graced the occasion as special guests, adding warmth and inspiration to the celebration. Speaking on the occasion, Dr. Ilankumaran Kaliamoorthy said, “At Apollo Children’s Hospital, we have always believed that true healing extends beyond medicine, it blossoms through empathy, connection, and care. With Happy Hearts, we are strengthening this bond by bringing together students and young patients in moments of shared joy and understanding. We look forward to carrying this initiative across all Apollo Hospitals in Chennai, nurturing a culture of kindness and emotional healing for every patient." The launch marks the beginning of a city-wide movement where regular school visits to Apollo Hospitals across Chennai, inspiring students to express kindness and support to children in care through letters, art, and small acts of joy. With “Happy Hearts,” Apollo Children’s Hospital once again reaffirms its commitment to holistic healing—celebrating not just recovery, but resilience, compassion, and community.

Chennai, 22 October, 2025: Apollo Hospitals, Greams Lane, Chennai, has another remarkable milestone in advanced cardiac care with the successful implantation of Tamil Nadu’s first Leadless Dual Chamber AVEIR Pacemaker. The complex procedure was performed by Dr. Karthigesan A. M., Senior Consultant Cardiologist & Electrophysiologist, and his expert cardiac team. The recipient was an 80-year-old male patient with hypertension, diabetes, a prior history of angioplasty, and chronic kidney disease on dialysis. He presented with a slow heart rate and recurrent loss of consciousness caused by age-related complete heart block. Given his high risk of infection with conventional pacemakers, the team opted for the innovative leadless pacemaker system a safer and more advanced alternative for such patients. The AVEIR dual chamber pacemaker represents the next generation of cardiac pacing technology. Unlike conventional pacemakers that require leads and a surgical pocket, this leadless system is implanted directly into the heart chambers through a minimally invasive catheter-based technique. This approach eliminates the need for open surgery and reduces  This cutting-edge device offers several advantages over traditional systems. The femoral vein approach allows for faster recovery and leaves no visible scar, while the absence of leads and a surgical pocket minimizes complications such as bleeding and infection. Its compact design enhances patient comfort, cosmetic outcomes, and long-term safety, while the wireless communication between the right atrium and ventricle enables synchronized, physiologic pacing that closely mimics the heart’s natural rhythm. The AVEIR system also integrates miniaturization, remote monitoring, and precision pacing, ensuring superior clinical outcomes and an improved quality of life.  Dr. Karthigesan A. M., Senior Consultant Cardiologist & Electrophysiologist, Apollo Hospitals, Greams lane, Chennai said, “the introduction of the AVEIR dual chamber leadless pacemaker marks a transformative step in cardiac rhythm management and a major milestone for Indian cardiology and Apollo Hospitals, Greams Lane, Chennai. This groundbreaking technology offers the precision of physiologic pacing while eliminating the traditional risks associated with leads and surgical pockets. We call it an ‘extraordinary leap for healthcare’ because it is compact, intelligent, and designed with the patient’s comfort and experience in mind. This advancement enables us to deliver safer, more comfortable, and longer-lasting cardiac care, and it has the potential to revolutionize the way pacemaker systems are used in the future.” Dr Ilankumaran kaliamoorthy, CEO, Apollo Hospitals, Chennai Region quoted, “At Apollo Hospitals, we are committed to adopting cutting-edge technologies that redefine patient care standards. The successful introduction of the AVEIR leadless pacemaker reinforces our focus on clinical excellence, innovation, and superior outcomes for our patients. This milestone strengthens our mission to bring world-class cardiac care within everyone’s reach.” Apollo Hospitals continues to lead the nation in cardiac innovation and excellence, integrating the latest medical technologies to enhance precision, safety, and patient comfort. With each such advancement, Apollo reaffirms its position as a pioneer in healthcare innovation and a global leader in patient-centric care.

~One in Four Adults Above 25 at Risk; Stroke Cases Rising Among Younger Populations~Chennai, 29 October 2025: Apollo Hospitals, Chennai, announced the expansion of its Apollo Advanced Stroke Network - a comprehensive, protocol-driven system designed to ensure rapid diagnosis and treatment for stroke patients across the city. With one in four individuals above 25 years of age now at risk, and stroke cases increasingly being reported among younger populations, this initiative comes at a crucial time to strengthen early detection and time-sensitive intervention in stroke care.This initiative marks a major leap forward in the fight against stroke - a condition where every minute counts. In stroke management, “Time is Brain”, as nearly 1,90,000 brain cells are lost every minute during an attack. The network ensures that patients across Apollo’s hospitals in Chennai receive uniform, high-quality, and time-sensitive care for both ischemic and hemorrhagic strokes.This milestone follows Apollo Hospitals’ Stroke Network launch in 2023, which laid the foundation for coordinated stroke response and public awareness initiatives. The expansion aims to reach a wider population, strengthen early detection, and improve survival and recovery rates.Globally, nearly 13 million people suffer a stroke each year, and in Chennai alone, around 10,000 cases are reported annually - underscoring the urgent need for awareness, preparedness, and timely medical response.The Apollo Advanced Stroke Network unites some of Chennai’s leading experts in neurology and neurovascular care, including Dr. Srinivasan Paramasivam, Senior Consultant – Neuro Endovascular Surgery; Dr. Kannah, Dr. Vijay Shankar, Dr. Muthukani, Dr. Arulselvan, and Dr. Satish Kumar, Dr. Sreenivas UM and all Senior Consultants in Neurology. Together, this multidisciplinary team brings extensive experience and expertise in stroke management, ensuring comprehensive and coordinated care for patients across the Apollo Hospitals network in Chennai.Dr. Srinivasan Paramasivam, Head of Neuro Endovascular Surgery at Apollo Hospitals, Greams Lane, Chennai, said “The Apollo Advanced Stroke Network represents an organized and time-efficient response system to expedite advanced care for stroke patients. Our focus is on offering neuroendovascular treatments such as mechanical thrombectomy for ischemic stroke, and endovascular and microsurgical treatments for hemorrhagic stroke. The goal is simple — to save more lives and improve outcomes through faster, smarter intervention.”Dr. Satish Kumar, Senior Consultant, Apollo Speciality Hospitals, OMR, added, “The emerging stroke treatments that we see today are time-dependent. We presently have 4.5 hours as the recognized time limit to initiate an intravenous thrombolysis in an indicated patient. Any sudden neurological development should be considered as a warning sign of stroke. Symptoms such as sudden vision loss, facial drooping, sudden weakness or numbness of one sided arm/leg, speech disturbances and  instability are key to understanding the condition. Awareness about stroke, the importance of time in stoke management and stroke prevention methods are abysmally low in our community. "Every minutes counts in stroke". We are pleased to join hands with stroke survivors to help create more awareness around this critical concern.”Dr. Sreenivas UM, Consultant Neurologist , Apollo Speciality Hospitals, Vanagaram spoke about the importance of AI in Acute Stroke Treatment. He said, “Artificial Intelligence is transforming the way we approach acute stroke care. Time is the most critical factor in stroke management, and AI-powered imaging and decision-support tools are helping us identify strokes faster and initiate treatment with unprecedented precision.”Dr. Ilankumaran Kaliamoorthy, Chief Executive Officer – Chennai Region, Apollo Hospitals, said, “Apollo Hospitals is delighted to launch the Apollo Advanced Stroke Network to respond to the needs of those with specific neurological conditions. We at Apollo appreciate that every minute counts and our stroke response model is designed on that principle. We also hope that the journeys of the survivors will enlighten and inspire stakeholders elsewhere to collaborate and fashion stroke care models that will greatly benefit their communities.”With this initiative, Apollo Hospitals Chennai continues to lead in advanced neuroscience and emergency care, offering a continuum of stroke management - from emergency intervention to rehabilitation and community education. The hospital remains deeply committed to public awareness, early prevention, and ensuring that no stroke goes untreated due to delay or lack of access.

Apollo Cancer Centre (ACC), India’s leading cancer care network, is spearheading awareness on hereditary cancers during Hereditary Cancer Awareness Week, on October 8, 2025, at Apollo Cancer Centre, Chennai. The initiative aims to educate families about inherited cancer risks, encourage early genetic testing, and promote proactive screening, empowering individuals to take control of their health before symptoms appear.  Hereditary cancers result from gene mutations passed down through families and account for about 5–10% of all cancer cases globally. In India, breast and ovarian cancers are among the most common hereditary cancers, with up to 10% linked to BRCA1 and BRCA2 mutations. Lynch syndrome, another inherited condition, is responsible for 2–3% of colorectal cancers, underscoring the importance of awareness and early intervention. At Apollo Cancer Centre, Chennai, a recent case of familial clustering demonstrated the power of timely diagnosis and treatment. Four members of a family from Guwahati—the mother, her two daughters, and her son—were diagnosed with cancers linked to Lynch syndrome. All four received treatment at Apollo and are now doing well, underscoring the life-changing impact of genetic awareness and multidisciplinary care. Dr. Venkat P, Senior Consultant – Surgical Oncology, Apollo Cancer Centre, Chennai, stated, “Cancer is not always sporadic; it can be inherited across generations. Genetic counselling and proactive screening are crucial to detect risk early and improve survival outcomes.”Dr. Priya Kapoor, Consultant – Surgical Oncology, Apollo Cancer Centre, Chennai, highlighted, “Families with multiple cases of colorectal, ovarian, or endometrial cancers must take their medical history seriously. Genetic testing, structured surveillance, regular colonoscopies, timely polyp removal, and preventive surgeries can help stop cancers before they develop fully.” Even the patients from Guwahati said: “When cancer struck four of us in our family, it felt devastating. But Apollo’s doctors guided us with care and compassion. Today, we carry hope instead of fear.” Reinforcing this vision, Mr. Harshad Reddy, Director – Group Oncology & International, Apollo Hospitals Enterprise Ltd, said, “Families might not realize that cancer may run in their genes until several loved ones are affected. At Apollo Cancer Centre, we are committed to bridging this gap through awareness, education, and proactive genetic care—because early action can change the course of a family’s future.”   Apollo Cancer Centre continues to lead India’s fight against hereditary cancers by raising awareness, driving prevention efforts, and instilling hope.  

Apollo Hospitals inaugurated a dedicated Centre for Respiratory Care at its Teynampet campus in Chennai, addressing the growing burden of respiratory illnesses in India. Established under the Apollo Institute of Pulmonology, the centre integrates advanced diagnostics, specialized treatments, and preventive programs to enhance pulmonary health.  The centre offers five structured screening and clinic programs targeting respiratory conditions, including basic asthma screening, advanced asthma management, interstitial lung disease evaluation, a quit smoking initiative, and early-stage pulmonary hypertension management. Each program provides thorough evaluation, personalized care plans, and patient education to promote long-term respiratory wellness. Equipped with state-of-the-art pulmonary function testing, sleep study facilities, bronchoscopy suites, and rehabilitation services, the centre supports seamless diagnosis and treatment. An integrated care model facilitates collaboration among pulmonologists, respiratory therapists, and critical care specialists to deliver effective outcomes. This launch underscores Apollo Hospitals’ dedication to tackling respiratory challenges linked to pollution, smoking, and post-COVID complications. Beyond clinical services, the Institute of Pulmonology prioritizes research, training, and community outreach to boost lung health awareness and prevention. Mr. Karan Puri, CEO of Apollo Specialty Hospital Teynampet & Apollo Proton Cancer Centre, highlighted that the institute enhances Apollo’s mission of accessible, patient-centred care through early diagnosis and coordinated management of respiratory diseases. Dr. Srinivas Rajagopala, Senior Consultant & Clinical Lead for Pulmonology, Sleep Medicine, and Lung Transplantation, emphasized that the centre streamlines the patient journey with structured screenings, precise diagnoses, and education. With this new centre, Apollo Hospitals strengthens its position as a leader in specialized healthcare, providing Chennai and the surrounding region a comprehensive hub for respiratory wellness grounded in innovation, expertise, and compassion. 

Apollo Hospitals has signed a landmark agreement with Iraq’s Ministry of Interior to manage and operate the Internal Security Force Hospital in Baghdad, marking a significant milestone in international healthcare collaboration. This partnership aims to deliver advanced medical care to Iraq's internal security forces and their families, while enhancing the hospital's infrastructure and healthcare standards. Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, emphasized the significance of the collaboration, stating, "This partnership will bring Apollo’s expertise in hospital management, advanced clinical care, and patient safety protocols to ensure the delivery of world-class healthcare services at the facility." She highlighted that this initiative strengthens healthcare services for Iraq's internal security personnel. Mr. Ouday Khudhair Saeed, First Secretary of Iraq, expressed confidence in the partnership's positive impact: "We are confident that this partnership will greatly benefit our internal security forces by providing them and their families with the quality healthcare they deserve." Dr. Prathap C. Reddy, Founder-Chairman of Apollo Hospitals, underlined how this agreement aligns with the hospital group's vision: “Heal in India, Heal by India, Heal from India.” He noted that this agreement reinforces the mission to extend India’s finest healthcare expertise across borders, bringing hope and healing to Iraq’s security forces and their families.” The collaboration signifies India’s expanding footprint in global healthcare, with Apollo Hospitals bringing world-class medical expertise to support critical healthcare infrastructure in Iraq. 

Apollo SHINE Foundation, the not-for-profit arm of Apollo Hospitals, has launched Catch’ Em Young, a nationwide initiative to screen one lakh college students for early signs of Non-Communicable Diseases (NCDs). The program, inaugurated at Women’s Christian College, Chennai, is India’s largest health initiative of its kind, targeting young adults. The launch was attended by Tamil Nadu Higher Education Minister Thiru Govi Chezhiaan and Thousand Lights constituency MLA Dr. Ezhilan Naganathan, who emphasized the importance of integrating preventive healthcare within higher education. Dr. Ezhilan Naganathan remarked that examining the screening results felt “like watching a horror movie,” but stressed that this “essential fear” is needed to drive proactive health behaviours and prevent illness later in life. Thiru Govi Chezhiaan highlighted that the findings highlight a worrying deficiency in awareness about non-communicable diseases across the state. He urged that the screening initiative should be expanded beyond Chennai to cover rural and other districts as well.   The initiative follows a decade of health screenings conducted by the foundation, which revealed alarming trends: 42% of students were overweight or obese, 4.5% had high blood pressure, 2.2% had increased blood sugar levels, 10% showed high triglyceride levels, and 30% were anaemic. Central obesity was also found in 10% of participants, underscoring the early onset of lifestyle-related risks such as poor diet and stress.   Through Catch ’Em Young, students will undergo comprehensive screenings that include BMI, waist circumference, hemoglobin, HbA1c, blood pressure, and triglycerides. The program seeks to build health awareness on campuses and promote preventive lifestyle choices. Dr. Ilankumaran Kaliamoorthy, CEO of Apollo Hospitals Chennai, noted that NCDs are no longer confined to middle age but are increasingly affecting college students. Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals, described the initiative as a crucial step toward timely intervention and sustained awareness, aimed at safeguarding the nation’s youth. 

Apollo Hospitals, Chennai, has reached a milestone with India’s first successful implantation of the Edwards SAPIEN 3 Ultra RESILIA transcatheter aortic valve (TAVI). This advanced valve offers enhanced durability, improved resistance to calcification, and fewer repeat procedures, enhancing outcomes for patients with severe aortic stenosis. The procedure was led by Dr. G. Sengottuvelu, Senior Interventional Cardiologist and Head of Structural Interventions at Apollo Hospitals, Chennai. The first recipient, a 70-year-old patient with severe calcific tricuspid aortic stenosis and a prior coronary stent, was considered high-risk for open-heart surgery. The minimally invasive TAVI technique provided a safe, durable solution for this complex case. Ms. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Group, noted that the introduction of the SAPIEN 3 Ultra RESILIA valve is a landmark in India’s cardiac care, offering patients a minimally invasive solution with proven durability. She added that by bringing global innovations to India, Apollo ensures world-class standards of care, improved long-term outcomes, while reinforcing its position for complex cardiac interventions. Dr. Sengottuvelu emphasized the clinical value of the breakthrough: “The RESILIA tissue technology is designed to minimize structural valve deterioration (SVD) and paravalvular leak (PVL), two major challenges in valve therapy, enabling safer treatment of high-risk patients and better long-term outcomes. Clinical studies show that the valve maintains over 99% freedom from deterioration at eight years, establishing it as the most durable option worldwide. For Indian patients, this innovation delivers faster recovery, fewer complications, and a healthier future.